table of content
1 Introduction to Research & Analysis Reports
1.1 COVID-19 Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global COVID-19 Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global COVID-19 Molecular Diagnostics Overall Market Size
2.1 Global COVID-19 Molecular Diagnostics Market Size: 2023 VS 2030
2.2 Global COVID-19 Molecular Diagnostics Market Size, Prospects & Forecasts: 2023-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key COVID-19 Molecular Diagnostics Players in Global Market
3.2 Global Companies COVID-19 Molecular Diagnostics Product & Technology
4 COVID-19 Molecular Diagnostics Companies Profiles
4.1 Cellex
4.1.1 Cellex Company Summary
4.1.2 Cellex Business Overview
4.1.3 Cellex COVID-19 Molecular Diagnostics Product Offerings & Technology
4.1.4 Cellex COVID-19 Molecular Diagnostics R&D, and Plans
4.2 Abbott
4.2.1 Abbott Company Summary
4.2.2 Abbott Business Overview
4.2.3 Abbott COVID-19 Molecular Diagnostics Product Offerings & Technology
4.2.4 Abbott COVID-19 Molecular Diagnostics R&D, and Plans
4.3 Roche
4.3.1 Roche Company Summary
4.3.2 Roche Business Overview
4.3.3 Roche COVID-19 Molecular Diagnostics Product Offerings & Technology
4.3.4 Roche COVID-19 Molecular Diagnostics R&D, and Plans
4.4 BioMedomics
4.4.1 BioMedomics Company Summary
4.4.2 BioMedomics Business Overview
4.4.3 BioMedomics COVID-19 Molecular Diagnostics Product Offerings & Technology
4.4.4 BioMedomics COVID-19 Molecular Diagnostics R&D, and Plans
4.5 BD
4.5.1 BD Company Summary
4.5.2 BD Business Overview
4.5.3 BD COVID-19 Molecular Diagnostics Product Offerings & Technology
4.5.4 BD COVID-19 Molecular Diagnostics R&D, and Plans
4.6 Henry Schein
4.6.1 Henry Schein Company Summary
4.6.2 Henry Schein Business Overview
4.6.3 Henry Schein COVID-19 Molecular Diagnostics Product Offerings & Technology
4.6.4 Henry Schein COVID-19 Molecular Diagnostics R&D, and Plans
4.7 Safecare Bio-Tech
4.7.1 Safecare Bio-Tech Company Summary
4.7.2 Safecare Bio-Tech Business Overview
4.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Product Offerings & Technology
4.7.4 Safecare Bio-Tech COVID-19 Molecular Diagnostics R&D, and Plans
4.8 Thermo Fisher
4.8.1 Thermo Fisher Company Summary
4.8.2 Thermo Fisher Business Overview
4.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Product Offerings & Technology
4.8.4 Thermo Fisher COVID-19 Molecular Diagnostics R&D, and Plans
4.9 Bio-rad
4.9.1 Bio-rad Company Summary
4.9.2 Bio-rad Business Overview
4.9.3 Bio-rad COVID-19 Molecular Diagnostics Product Offerings & Technology
4.9.4 Bio-rad COVID-19 Molecular Diagnostics R&D, and Plans
4.10 Agilent
4.10.1 Agilent Company Summary
4.10.2 Agilent Business Overview
4.10.3 Agilent COVID-19 Molecular Diagnostics Product Offerings & Technology
4.10.4 Agilent COVID-19 Molecular Diagnostics R&D, and Plans
4.11 Ortho Clinical Diagnostics
4.11.1 Ortho Clinical Diagnostics Company Summary
4.11.2 Ortho Clinical Diagnostics Business Overview
4.11.3 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product Offerings & Technology
4.11.4 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics R&D, and Plans
4.12 Zhejiang Orient Gene Biotech
4.12.1 Zhejiang Orient Gene Biotech Company Summary
4.12.2 Zhejiang Orient Gene Biotech Business Overview
4.12.3 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product Offerings & Technology
4.12.4 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics R&D, and Plans
4.13 Innovita Biological Technology
4.13.1 Innovita Biological Technology Company Summary
4.13.2 Innovita Biological Technology Business Overview
4.13.3 Innovita Biological Technology COVID-19 Molecular Diagnostics Product Offerings & Technology
4.13.4 Innovita Biological Technology COVID-19 Molecular Diagnostics R&D, and Plans
4.14 Guangzhou Wondfo Biotech
4.14.1 Guangzhou Wondfo Biotech Company Summary
4.14.2 Guangzhou Wondfo Biotech Business Overview
4.14.3 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product Offerings & Technology
4.14.4 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics R&D, and Plans
4.15 Guangdong Hecin-Scientific
4.15.1 Guangdong Hecin-Scientific Company Summary
4.15.2 Guangdong Hecin-Scientific Business Overview
4.15.3 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product Offerings & Technology
4.15.4 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics R&D, and Plans
4.16 Dynamiker Biotechnology (Tianjin)
4.16.1 Dynamiker Biotechnology (Tianjin) Company Summary
4.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
4.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product Offerings & Technology
4.16.4 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics R&D, and Plans
4.17 ADVAITE
4.17.1 ADVAITE Company Summary
4.17.2 ADVAITE Business Overview
4.17.3 ADVAITE COVID-19 Molecular Diagnostics Product Offerings & Technology
4.17.4 ADVAITE COVID-19 Molecular Diagnostics R&D, and Plans
4.18 Mayo Clinic Laboratories
4.18.1 Mayo Clinic Laboratories Company Summary
4.18.2 Mayo Clinic Laboratories Business Overview
4.18.3 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product Offerings & Technology
4.18.4 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics R&D, and Plans
4.19 Chembio Diagnostics
4.19.1 Chembio Diagnostics Company Summary
4.19.2 Chembio Diagnostics Business Overview
4.19.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Product Offerings & Technology
4.19.4 Chembio Diagnostics COVID-19 Molecular Diagnostics R&D, and Plans
4.20 Mount Sinai Laboratory
4.20.1 Mount Sinai Laboratory Company Summary
4.20.2 Mount Sinai Laboratory Business Overview
4.20.3 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product Offerings & Technology
4.20.4 Mount Sinai Laboratory COVID-19 Molecular Diagnostics R&D, and Plans
4.21 QIAGEN
4.21.1 QIAGEN Company Summary
4.21.2 QIAGEN Business Overview
4.21.3 QIAGEN COVID-19 Molecular Diagnostics Product Offerings & Technology
4.21.4 QIAGEN COVID-19 Molecular Diagnostics R&D, and Plans
4.22 Bioer
4.22.1 Bioer Company Summary
4.22.2 Bioer Business Overview
4.22.3 Bioer COVID-19 Molecular Diagnostics Product Offerings & Technology
4.22.4 Bioer COVID-19 Molecular Diagnostics R&D, and Plans
4.23 Biosynex
4.23.1 Biosynex Company Summary
4.23.2 Biosynex Business Overview
4.23.3 Biosynex COVID-19 Molecular Diagnostics Product Offerings & Technology
4.23.4 Biosynex COVID-19 Molecular Diagnostics R&D, and Plans
4.24 Esco
4.24.1 Esco Company Summary
4.24.2 Esco Business Overview
4.24.3 Esco COVID-19 Molecular Diagnostics Product Offerings & Technology
4.24.4 Esco COVID-19 Molecular Diagnostics R&D, and Plans
4.25 Analytik Jena
4.25.1 Analytik Jena Company Summary
4.25.2 Analytik Jena Business Overview
4.25.3 Analytik Jena COVID-19 Molecular Diagnostics Product Offerings & Technology
4.25.4 Analytik Jena COVID-19 Molecular Diagnostics R&D, and Plans
4.26 Techne
4.26.1 Techne Company Summary
4.26.2 Techne Business Overview
4.26.3 Techne COVID-19 Molecular Diagnostics Product Offerings & Technology
4.26.4 Techne COVID-19 Molecular Diagnostics R&D, and Plans
4.27 Da An Gene
4.27.1 Da An Gene Company Summary
4.27.2 Da An Gene Business Overview
4.27.3 Da An Gene COVID-19 Molecular Diagnostics Product Offerings & Technology
4.27.4 Da An Gene COVID-19 Molecular Diagnostics R&D, and Plans
4.28 BGI
4.28.1 BGI Company Summary
4.28.2 BGI Business Overview
4.28.3 BGI COVID-19 Molecular Diagnostics Product Offerings & Technology
4.28.4 BGI COVID-19 Molecular Diagnostics R&D, and Plans
4.29 Shanghai ZJ Bio-Tech
4.29.1 Shanghai ZJ Bio-Tech Company Summary
4.29.2 Shanghai ZJ Bio-Tech Business Overview
4.29.3 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product Offerings & Technology
4.29.4 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics R&D, and Plans
5 Sights by Region
5.1 By Region - Global COVID-19 Molecular Diagnostics Market Size, 2024 & 2030
5.2 By Region - Global COVID-19 Molecular Diagnostics Revenue, (2024-2030)
5.3 United States
5.3.1 Key Players of COVID-19 Molecular Diagnostics in United States
5.3.2 United States COVID-19 Molecular Diagnostics Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of COVID-19 Molecular Diagnostics in Europe
5.4.2 Europe COVID-19 Molecular Diagnostics Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of COVID-19 Molecular Diagnostics in China
5.5.2 China COVID-19 Molecular Diagnostics Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global COVID-19 Molecular Diagnostics Market Size Markets, 2024 & 2030
6.2 High-throughput Sequencing
6.3 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
6.4 Immunological Detection
7 Sights by Application
7.1 By Application - Global COVID-19 Molecular Diagnostics Market Size, 2024 & 2030
7.2 Hospitals
7.3 Scientific Research
7.4 Biodiagnostics
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
